Jack Anders
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Revolution Medicines, Inc. (RVMD)
Proxy statement
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | $523,333 | $3,588,111 |
| 2024 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | $473,333 | $3,292,532 |
| 2023 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | $438,384 | $3,047,529 |
| 2022 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | $371,000 | $1,947,461 |
| 2021 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | $311,333 | $1,509,614 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.